Acute onset dermatomyositis with NXP‐2 antibodies after Sars‐CoV‐2 vaccination in a 20‐year‐old female
Abstract Dermatomyositis is an autoimmune connective tissue disease with variable cutaneous and systemic manifestations. While multiple cutaneous reactions to SARS‐CoV‐2 vaccination have been described, vaccine‐associated emergence of dermatomyositis has rarely been reported. Cases of deterioration...
Main Authors: | Emma Porter, Berbie Byrne, Sumreen Sarfaraz, Niamh Leonard, Sinead Field |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-06-01
|
Series: | JEADV Clinical Practice |
Subjects: | |
Online Access: | https://doi.org/10.1002/jvc2.136 |
Similar Items
-
Early improvement of nailfold videocapillaroscopy abnormalities in dermatomyositis patients with anti‐NXP‐2 antibody
by: Naoki Mugii, et al.
Published: (2023-12-01) -
Dermatomyositis with Eosinophils
by: Isabella I. Sanchez, et al.
Published: (2023-11-01) -
Calcinosis cutis in a young man with dermatomyositis
by: Marco Krasselt, et al.
Published: (2023-12-01) -
Dermatomyositis associated with omalizumab therapy for severe asthma: a case report
by: Samira Jeimy, et al.
Published: (2019-01-01) -
Recurrence of juvenile dermatomyositis 8 years after remission
by: Ken Muramatsu, MD, et al.
Published: (2017-01-01)